journal article·2018-10Open access

Surface modification of polymer nanoparticles with native albumin for enhancing drug delivery to solid tumors

Hyesun Hyun, Joonyoung Park, Kiela Willis, Ji Eun Park, L. Tiffany Lyle, Wooin Lee, Yoon Yeo

Biomaterials· Volume 180

Abstract

Albumin is a promising surface modifier of nanoparticulate drug delivery systems. Serving as a dysopsonin, albumin can protect circulating nanoparticles (NPs) from the recognition and clearance by the mononuclear phagocytic system (MPS). Albumin may also help transport the NPs to solid tumors based on the increased consumption by cancer cells and interactions with the tumor microenvironment. Several studies have explored the benefits of surface-bound albumin to enhance NP delivery to tumors. However, it remains unknown how the surface modification process affects the conformation of albumin and the performance of the albumin-modified NPs. We use three different surface modification methods including two prevalent approaches (physisorption and interfacial embedding) and a new method based on dopamine polymerization to modify the surface of poly(lactic-co-glycolic acid) NPs with albumin and compare the extent of albumin binding, conformation of the surface-bound albumin, and biological performances of the albumin-coated NPs. We find that the dopamine polymerization method preserves the albumin structure, forming a surface layer that facilitates NP transport and drug delivery into tumors via the interaction with albumin-binding proteins. In contrast, the interfacial embedding method creates NPs with denatured albumin that offers no particular benefit to the interaction with cancer cells but rather promotes the MPS uptake via direct and indirect interactions with scavenger receptor A. This study demonstrates that the surface-bound albumin can bring distinct effects according to the way they interact with NP surface and thus needs to be controlled in order to achieve favorable therapeutic outcomes.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Polymer Surface Interaction Studies · Blood properties and coagulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (86)

Show source-provided references
1. The effect of nanoparticle size, shape, and surface chemistry on biological systems10.1146/annurev-bioeng-071811-150124 ↗
2. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake10.1021/ja2084338 ↗
3. A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma10.1016/j.addr.2010.09.001 ↗
4. The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors10.1248/bpb.b13-00059 ↗
5. 'Stealth' corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption10.1016/S0927-7765(99)00156-3 ↗
6. Regulation of endothelial permeability via paracellular and transcellular transport pathways10.1146/annurev-physiol-021909-135833 ↗
7. Pre-coating with serum albumin reduces receptor-mediated hepatic disposition of polystyrene nanosphere: implications for rational design of nanoparticles10.1016/j.jconrel.2004.07.028 ↗
8. Effect of coupling of albumin onto surface of PEG liposome on its in vivo disposition10.1016/j.ijpharm.2006.08.026 ↗
9. Effects of albumin on the phagocytosis of polystyrene spherules by rabbit polymorphonuclear leucocytes10.1002/jcp.1040970105 ↗
10. Preformed albumin corona, a protective coating for nanoparticles based drug delivery system10.1016/j.biomaterials.2013.07.102 ↗
11. Plasma protein (albumin) catabolism by the tumor itself–implications for tumor metabolism and the genesis of cachexia10.1016/S1040-8428(97)00015-2 ↗
12. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells10.1038/nature12138 ↗
13. Albumin uptake and transcytosis in endothelial cells in vivo induced by albumin-binding protein10.1152/ajplung.2001.281.6.L1512 ↗
14. Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway10.1074/jbc.272.41.25968 ↗
15. Albondin-mediated capillary permeability to albumin. Differential role of receptors in endothelial transcytosis and endocytosis of native and modified albumins10.1016/S0021-9258(17)37571-3 ↗
16. Impact of albumin on drug delivery - new applications on the horizon10.1016/j.jconrel.2011.09.069 ↗
17. SPARC expression in head and neck cancer correlates with tumor response to nanoparticle albumin-bound paclitaxel (nab-paclitaxel, ABI-007, Abraxane)
18. Nab-Paclitaxel (Abraxane(®)): an albumin-bound cytotoxic exploiting natural delivery mechanisms into tumors10.1186/bcr2282 ↗
19. Albumin corona on nanoparticles - a strategic approach in drug delivery10.3109/10717544.2015.1048488 ↗
20. Enhanced biostability of nanoparticle-based drug delivery systems by albumin corona10.2217/nnm.14.86 ↗
21. Efficient chemotherapy of rat glioblastoma using doxorubicin-loaded PLGA nanoparticles with different stabilizers10.1371/journal.pone.0019121 ↗
22. Surface modification of PLGA nanoparticles via human serum albumin conjugation for controlled delivery of docetaxel10.1186/2008-2231-21-58 ↗
23. Photosensitizer-conjugated human serum albumin nanoparticles for effective photodynamic therapy10.7150/thno/v01p0230 ↗
24. Cryptic epitopes of albumin determine mononuclear phagocyte system clearance of nanomaterials10.1021/nn405830g ↗
25. Secondary structure of corona proteins determines the cell surface receptors used by nanoparticles10.1021/jp502624n ↗
26. Spectroscopic studies on the interaction of colloidal capped CdS nanoparticles with bovine serum albumin10.1016/j.colsurfb.2009.03.030 ↗
27. The interaction of bovine serum albumin with doxorubicin-loaded superparamagnetic iron oxide nanoparticles: spectroscope and molecular modelling identification10.3109/17435390.2011.634079 ↗
28. Interaction of ifosfamide-loaded superparamagnetic iron oxide nanoparticles with human serum albumin—a biophysical study10.1007/s12247-014-9199-9 ↗
29. Mussel-inspired surface chemistry for multifunctional coatings10.1126/science.1147241 ↗
30. Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers10.1021/nn405809c ↗
31. Polydopamine and its derivative materials: synthesis and promising applications in energy, environmental, and biomedical fields10.1021/cr400407a ↗
32. Non-covalent self-assembly and covalent polymerization Co-Contribute to polydopamine formation10.1002/adfm.201201156 ↗
33. Facile conjugation of biomolecules onto surfaces via mussel adhesive protein inspired coatings10.1002/adma.200801222 ↗
34. Mussel-inspired encapsulation and functionalization of individual yeast cells10.1021/ja1100189 ↗
35. Pulse proteolysis: a simple method for quantitative determination of protein stability and ligand binding10.1038/nmeth740 ↗
36. Role of Arg-410 and Tyr-411 in human serum albumin for ligand binding and esterase-like activity10.1042/bj3490813 ↗
37. Boonyaratanakornkit, Douglas S. Clark. Esterase activity of bovine serum albumin up to 160 ◦C: a new benchmark for biocatalysis10.1016/j.enzmictec.2007.10.007 ↗
38. Impedance-based cell monitoring: barrier properties and beyond10.1186/2045-8118-10-5 ↗
39. Determination of subcutaneous tumor size in athymic (nude) mice10.1007/BF00300234 ↗
40. Specific growth rate versus doubling time for quantitative characterization of tumor growth rate10.1158/0008-5472.CAN-06-3822 ↗
41. Hydration layer-mediated pairwise interaction of nanoparticles10.1021/acs.nanolett.5b04808 ↗
42. Interfacial water thickness at inorganic nanoconstructs and biomolecules: size matters10.1016/j.physleta.2016.03.015 ↗
43. Albumin-coated nanocrystals for Carrier-free delivery of paclitaxel
44. Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells10.1016/S0142-9612(02)00525-2 ↗
45. Understanding the nanoparticle–protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles10.1073/pnas.0608582104 ↗
46. Genetic factors controlling structure and expression of apolipoproteins B and E in mice10.1016/S0021-9258(18)47607-7 ↗
47. Plasma lipoproteins: apolipoprotein structure and function10.1016/S0022-2275(20)34443-6 ↗
48. Endothelial caveolin-1 plays a major role in the development of atherosclerosis10.1007/s00441-013-1767-7 ↗
49. Plasmin promotes an endothelium-dependent adhesion of neutrophils. Involvement of platelet activating factor and P-selectin10.1161/01.CIR.93.12.2152 ↗
50. Nanoparticle accumulation and transcytosis in brain endothelial cell layers10.1039/c3nr02905k ↗
51. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway10.1083/jcb.150.5.1057 ↗
52. gp60 is an albumin-binding glycoprotein expressed by continuous endothelium involved in albumin transcytosis
53. Understanding the robust physisorption between bovine serum albumin and amphiphilic polymer coated nanoparticles10.1021/acsami.5b08386 ↗
54. VEGF-induced mobilization of caveolae and increase in permeability of endothelial cells10.1152/ajpcell.00292.2001 ↗
55. Enhancement of proinflammatory and procoagulant responses to silica particles by monocyte-endothelial cell interactions10.1186/1743-8977-9-36 ↗
56. Potential proinflammatory effects of hydroxyapatite nanoparticles on endothelial cells in a monocyte–endothelial cell coculture model
57. KLF4 inhibition of lung cancer cell invasion by suppression of SPARC expression10.4161/cbt.9.7.11106 ↗
58. Docetaxel-carboxymethylcellulose nanoparticles target cells via a SPARC and albumin dependent mechanism10.1016/j.biomaterials.2015.04.032 ↗
59. Novel transgenic mouse model for studying human serum Albumin as A Biomarker of carcinogenic exposure10.1021/acs.chemrestox.5b00529 ↗
60. Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates10.1073/pnas.1305804110 ↗
61. Retro-inverso d-peptide-modified hyaluronic acid/bioreducible hyperbranched poly(amido amine)/pDNA core-shell ternary nanoparticles for the dual-targeted delivery of short hairpin RNA-encoding plasmids10.1016/j.actbio.2017.04.024 ↗
62. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake10.1016/S0168-3659(02)00127-X ↗
63. Pearson VVJaSH. Biomolecular corona on nanoparticles: a survey of recent literature and its
64. MARCO, a macrophage scavenger receptor highly expressed in rodents, mediates dalcetrapib-induced uptake of lipids by rat and mouse macrophages10.1016/j.tiv.2010.01.002 ↗
65. Contrasting effects of nanoparticle binding on protein denaturation10.1021/jp506135m ↗
66. Nanoparticle-induced unfolding of fibrinogen promotes Mac-1 receptor activation and inflammation10.1038/nnano.2010.250 ↗
67. Caspase-1-induced pyroptotic cell death10.1111/j.1600-065X.2011.01044.x ↗
68. Monocyte Caspase-1 is released in a stable, active high molecular weight complex distinct from the unstable cell lysate-activated Caspase-110.1371/journal.pone.0142203 ↗
69. Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis10.1371/journal.pone.0057135 ↗
70. Application of WGA lectin staining for visualization of the connective tissue in skeletal muscle, bone and ligament/tendon studies10.1002/jemt.20865 ↗
71. Use of labeled tomato lectin for imaging vasculature structures10.1007/s00418-014-1301-3 ↗
72. Three-dimensional MR mapping of angiogenesis with α5β1(ανβ3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse model10.1096/fj.08-112060 ↗
73. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice10.1172/JCI965 ↗
74. Openings between defective endothelial cells explain tumor vessel leakiness10.1016/S0002-9440(10)65006-7 ↗
75. Characterization of sinusoidal endothelial cells of the liver and bone marrow using an intravital lectin injection method10.1007/s10735-008-9186-x ↗
76. High affinity binding of paclitaxel to human serum albumin
77. Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease10.1002/hep.22109 ↗
78. Combination therapy using Co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo10.1038/srep22390 ↗
79. Regulation of enzyme activity through interactions with nanoparticles10.3390/ijms10104198 ↗
80. Modulating the activity of protein conjugated to gold nanoparticles by site-directed orientation and surface density of bound protein10.1021/am5084545 ↗
81. Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes10.1021/ar500190q ↗
82. Serum protein identification and quantification of the corona of 5, 15 and 80 nm gold nanoparticles10.1088/0957-4484/24/26/265103 ↗
83. Macrophage scavenger receptor a mediates adhesion to apolipoproteins A-I and E10.1021/bi9013769 ↗
84. Murine macrophage scavenger receptor: in vivo expression and function as receptor for macrophage adhesion in lymphoid and non-lymphoid organs10.1002/eji.1830250224 ↗
85. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy10.1016/S0168-3659(01)00275-9 ↗
86. SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice10.1136/gutjnl-2013-305559 ↗